European Patent Bulletin 2012/09 - European Patent Office
19.12.2012 • Views
Share Embed Flag

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) I.1(1)<br />

TISSUE KALLIKREIN FOR THE<br />

TREATMENT OF SCHIZOPHRENIA AND<br />

BIPOLAR DISORDER<br />

KALLICRÉINE TISSULAIRE POUR LE<br />

TRAITEMENT DE LA SCHIZOPHRÉNIE ET<br />

DU TROUBLE BIPOLAIRE<br />

(71) Sanomune Inc., 200-135 Innovation Drive,<br />

Winnipeg, MB R3T 6A8, CA<br />

(72) WILLIAMS, Mark, Winnipeg Manitoba R2M<br />

2J4, CA<br />

CHARLES, Matthew, Winnipeg Manitoba<br />

R3L 0H3, CA<br />

(74) Harding, Charles Thomas, D Young & Co<br />

LLP 120 Holborn, London EC1N 2DY, GB<br />

(51) A61K 38/48 (11) 2 421 554 A1*<br />

A61P 25/28<br />

(25) En (26) En<br />

(21) 10766547.3 (22) 22.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) CA 2010/000575 22.04.2010<br />

(87) WO 2010/121361 2010/43 28.10.2010<br />

(30) 22.04.20<strong>09</strong> US 171579 P<br />

(54) GEWEBE-KALLIKREIN ZUR BEHAND-<br />

LUNG VON MORBUS HUNTINGTON<br />

TISSUE KALLIKREIN FOR THE<br />

TREATMENT OF HUNTINGTON'S<br />

DISEASE<br />

KALLICRÉINE TISSULAIRE POUR LE<br />

TRAITEMENT DE LA MALADIE D'HUN-<br />

TINGTON<br />

(71) Sanomune Inc., 200-135 Innovation Drive,<br />

Winnipeg, MB R3T 6A8, CA<br />

(72) WILLIAMS, Mark, Winnipeg Manitoba R2M<br />

2J4, CA<br />

CHARLES, Matthew, Winnipeg Manitoba<br />

R3L 0H3, CA<br />

(74) Harding, Charles Thomas, D Young & Co<br />

LLP 120 Holborn, London EC1N 2DY, GB<br />

A61K 39/00 → (51) C07K 14/47<br />

(51) A61K 39/008 (11) 2 421 555 A2*<br />

(25) En (26) En<br />

(21) 10719953.1 (22) 23.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) GB 2010/000815 23.04.2010<br />

(87) WO 2010/122310 2010/43 28.10.2010<br />

(88) 31.03.2011<br />

(30) 23.04.20<strong>09</strong> GB <strong>09</strong>06906<br />

(54) NUKLEINSÄUREMOLEKÜL<br />

NUCLEIC ACID MOLECULE<br />

MOLÉCULE D'ACIDE NUCLÉIQUE<br />

(71) The University Of York, Heslington Hall<br />

Heslington, York, Yorkshire YO10 5DD, GB<br />

University Of Edinburgh, Old College South<br />

Bridge, Edinburgh EH8 9YL, GB<br />

(72) KAYE, Paul, York YO10 5DD, GB<br />

SMITH, Deborah, York YO10 5DD, GB<br />

LACEY, Charles, York YO10 5DD, GB<br />

AEBISCHER, Anton, 13302 Berlin, DE<br />

(74) Docherty, Robert Charles, Symbiosis IP<br />

Limited Apollo House Eboracum Way,<br />

Heworth Green, York YO31 7RE, GB<br />

(51) A61K 39/02 (11) 2 421 556 A1*<br />

(25) En (26) En<br />

(21) 10717367.6 (22) 23.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

BA ME RS<br />

(86) US 2010/032149 23.04.2010<br />

(87) WO 2010/124154 2010/43 28.10.2010<br />

(30) 24.04.20<strong>09</strong> US 172543 P<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) IMPFSTOFFE MIT ABGESCHWÄCHTEN<br />

STÄMMEN VON MYCOPLASMA BOVIS<br />

UND ABSCHWÄCHUNGSVERFAHREN<br />

VACCINES COMPRISING ATTENUATED<br />

MYCOPLASMA BOVIS STRAINS AND<br />

METHOD FOR THE ATTENUATION<br />

VACCINS COMPRENANT DES SOUCHES<br />

DE MYCOPLASMA BOVIS ATTÉNUÉES ET<br />

PROCÉDÉ D'ATTÉNUATION<br />

(71) Boehringer Ingelheim Vetmedica, Inc., 2621<br />

North Belt Highway, St. Joseph, MO 64506-<br />

2002, US<br />

(72) BECK, Michael, St. Joseph Missouri 64506,<br />

US<br />

KNITTEL, Jeffrey, St. Joseph Missouri<br />

64506, US<br />

(74) Hammann, Heinz, et al, Boehringer Ingelheim<br />

GmbH Corporate <strong>Patent</strong>s Binger<br />

Strasse 173, 55216 Ingelheim am Rhein, DE<br />

(51) A61K 39/04 (11) 2 421 557 A1*<br />

A61P 11/00 C07K 14/35<br />

C07K 19/00<br />

(25) En (26) En<br />

(21) 10766664.6 (22) 23.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) DK 2010/000054 23.04.2010<br />

(87) WO 2010/121618 2010/43 28.10.2010<br />

(30) 24.04.20<strong>09</strong> DK 20<strong>09</strong>00539<br />

(54) TUBERKULOSE-TB-IMPSTOFF ZUR RE-<br />

AKTIVIERUNGSVERHINDERUNG<br />

A TUBERCULOSIS TB VACCINE TO<br />

PREVENT REACTIVATION<br />

VACCIN CONTRE LA TUBERCULOSE TB<br />

POUR PRÉVENIR UNE RÉACTIVATION<br />

(71) Statens Serum Institut, Orestads Boulevard<br />

5, 2300 Copenhagen S, DK<br />

(72) DIETRICH, Jes, DK-2200 Copenhagen N, DK<br />

ANDERSEN, Peter, DK-2700 Brønshøj, DK<br />

LUNDBERG, Carina, Vingsbo, S-23642 Höllviken,<br />

SE<br />

HOANG, Truc, Thi, Kim, Than, DK-2300<br />

Copenhagen S, DK<br />

(74) Plougmann & Vingtoft A/S, Sundkrogsgade<br />

9 P.O. Box 831, 2100 Copenhagen Ø, DK<br />

A61K 39/145 → (51) A61K 38/08<br />

(51) A61K 39/395 (11) 2 421 558 A1*<br />

(25) En (26) En<br />

(21) 10714820.7 (22) 20.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) US 2010/031740 20.04.2010<br />

(87) WO 2010/123891 2010/43 28.10.2010<br />

(30) 20.04.20<strong>09</strong> US 171008 P<br />

21.04.20<strong>09</strong> US 171318 P<br />

26.05.20<strong>09</strong> US 181195 P<br />

(54) ADJUVANTE KREBSTHERAPIE<br />

ADJUVANT CANCER THERAPY<br />

THÉRAPIE ADJUVANTE DE CANCER<br />

(71) Genentech, Inc., One DNA Way, South San<br />

Francisco, CA 94080-4990, US<br />

NSABP Foundation, Inc., Four Allegheny<br />

Center, 5th Floor, Pittsburgh, PA 15212, US<br />

(72) FYFE, Gwendolyn, San Francisco California<br />

94133, US<br />

HEDRICK, Eric, Summit New Jersey 07901,<br />

US<br />

MASS, Robert D., Mill Valley California<br />

94941, US<br />

WOLMARK, Norman, Pittsburgh PA 15212,<br />

US<br />

(74) Denison, Christopher Marcus, Mewburn Ellis<br />

LLP 33 Gutter Lane, London EC2V 8AS, GB<br />

44<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>09</strong>/<strong>2012</strong>) 29.02.<strong>2012</strong><br />

(51) A61K 39/395 (11) 2 421 559 A2*<br />

A61P 19/00<br />

(25) En (26) En<br />

(21) 10767880.7 (22) 26.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/032373 26.04.2010<br />

(87) WO 2010/124276 2010/43 28.10.2010<br />

(88) 03.02.2011<br />

(30) 24.04.20<strong>09</strong> US 172539 P<br />

(54) ANTI-TGF-BETA-AKTIVIERUNG VON KNO-<br />

CHENZELLFUNKTIONEN UND KNOCHEN-<br />

WACHSTUM<br />

ANTI-TGF-BETA INDUCTION OF BONE<br />

CELL FUNCTION AND BONE GROWTH<br />

INDUCTION ANTI-TGF-SS DE LA FONC-<br />

TION DE CELLULE OSSEUSE ET DE LA<br />

CROISSANCE OSSEUSE<br />

(71) Vanderbilt University, <strong>Office</strong> Of Technology<br />

Transfer 305 Kirkland Hall, Nashville,<br />

Tennessee 37240, US<br />

(72) EDWARDS, James R., Nashville, TN 37232,<br />

US<br />

MUNDY, Gregory R., "deceased", US<br />

(74) Dehmel, Albrecht, Dehmel & Bettenhausen<br />

<strong>Patent</strong>anwälte Herzogspitalstrasse 11, 80331<br />

München, DE<br />

A61K 39/395 → (51) A61K 9/06<br />

A61K 39/395 → (51) A61K 31/42<br />

A61K 39/395 → (51) A61K 48/00<br />

A61K 39/395 → (51) A61P 3/04<br />

A61K 39/395 → (51) C07K 14/05<br />

A61K 39/395 → (51) C07K 14/47<br />

A61K 39/395 → (51) C07K 16/28<br />

A61K 45/06 → (51) A61K 9/50<br />

A61K 47/10 → (51) A61K 31/167<br />

A61K 47/26 → (51) A61K 31/00<br />

A61K 47/30 → (51) A61K 9/52<br />

A61K 47/34 → (51) A61K 8/04<br />

A61K 47/34 → (51) A61K 9/06<br />

(51) A61K 47/36 (11) 2 421 560 A2*<br />

A61K 9/00<br />

(25) En (26) En<br />

(21) 10716862.7 (22) 23.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) GB 2010/050673 23.04.2010<br />

(87) WO 2010/122357 2010/43 28.10.2010<br />

(88) 31.03.2011<br />

(30) 24.04.20<strong>09</strong> GB <strong>09</strong>07019<br />

(54) ABGABESYSTEME<br />

DELIVERY SYSTEMS<br />

SYSTÈMES D'ADMINISTRATION<br />

(71) Oxford Pharmascience Ltd, Centre for Innovation<br />

& Enterprise Oxford University<br />

Begbroke Science Park Sandy Lane, Yarnton,<br />

Oxfordshire OX5 1PF, GB<br />

(72) BRAVO CORDERO, Marcelo, Leonardo,<br />

Oxford Oxfordshire OX2 6TQ, GB<br />

JONES, Huw, Lyn, Nottingham Nottinghamshire<br />

NG8 2AR, GB<br />

KANJI, Nazim, Mohamed, Leicester Leicestershire<br />

LE5 1QS, GB

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!